Anti-Respiratory Syncytial Virus Glycoprotein F(Palivizumab Biosimilar) Antibody

Details and Advantages

Code: 400-577-001

Specification:

Applications: ELISA,Flow Cyt

Reactivity: Respiratory Syncytial Virus Glycoprotein F

Conjugate: Unconjugated

Advantages:

High lot-to-lot consistency Increased sensitivity and higher affinity Animal-free production

Product Description Manual MSDS FAQ Citations

Product Detail

Description:
Anti-Respiratory Syncytial Virus Glycoprotein F(Palivizumab Biosimilar) Antibody is a biosimilar antibody directed against Respiratory Syncytial Virus Glycoprotein F.

Isotype: Human IgG1
Conjugate: Unconjugated
Specificity: Respiratory Syncytial Virus Glycoprotein F
Clonality: Monoclonal
Purity: Recombinant Expression and Affinity purified
Concentration: 1mg/ml
Formation: Liquid, 10mM PBS (pH 7.5)
Storage: Store at –20 °C, (Avoid freeze/thaw cycles)

FAQ

Citations

Related Products

Anti-MST1R/CD136(Narnatumab Biosimilar) Antibody

Anti-IL17A(Xeligekimab Biosimilar) Antibody

Anti-ICAM1/CD54(Bersanlimab Biosimilar) Antibody

Anti-pro-MSTN/pro-GDF8(Apitegromab Biosimilar) Antibody

Anti-IGF1R/CD221(Cixutumumab Biosimilar) Antibody

Anti-OX40L/CD134(Oxelumab Biosimilar) Antibody

Anti-IFNG(Emapalumab Biosimilar) Antibody

Anti-Alpha Ferroprotein(Tacatuzumab Biosimilar) Antibody